Interestingly, multiple studies have demonstrated associations between COVID-19 and increased circulating concentrations of the anaphylatoxins C3a and C5a, C5a receptor expression, and the terminal pathway effector molecule C5b9 (7–10, 34, 35). The gene discussed is C3; the disease is COVID-19.